Capvaxive, Injektionslösung in Fertigspritze

7680697810019 CH-69781 Injektionslösung in Fertigspritze

No image available

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionslösung in Fertigspritze
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
07/10/2025
Summary of Product Characteristics
Français
07/10/2025
Summary of Product Characteristics
Italien
07/10/2025

Detailed composition

Substance Quantity Type Category
polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 6A conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 7F conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 8 conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 9N conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 10A conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 11A conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 12F conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 15A conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 15B de-O-acetylatus conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 16F conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 17F conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 19A conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 20A conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 22F conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 23A conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 23B conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 24F conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 31 conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 33F conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 35B conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
proteinum corynebacteriae diphtheriae CRM 197
65.0 UG Substance WIIS
polysorbatum 20
- Substance HNIDK
histidinum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
natrium
1.77 MG Substance HBESI
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 85.85
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2026

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
69781
Drug name
Capvaxive, Injektionslösung in Fertigspritze
Galenic form
INLFS
ATC Code
J07AL02
Authorization status
Z
Dispensing category
B
First authorization
23/09/2025
Authorization expiration date
22/09/2030
IT Number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Pneumokokken-Infektionen der Serotypen 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, de-O-acetyliert 15B, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F, 35B

Package details

Description (FR)
CAPVAXIVE sol inj 4 µg 1 pce
Description (DE)
CAPVAXIVE Inj Lös 4 µg 1 Stk
Market launch
01/12/2025
Narcotic (BTM)
No

Other package sizes (1)

CAPVAXIVE sol inj ser prérempl 4 µg 10 pce
10 FESP
GTIN: 7680697810026
View
Buy us a coffee Explore the data